Table 3.
National antimicrobial consumption, contributing to 90% of total national antibiotic use in 2019 and 2020, and categorized by WHO AWaRe category (Access/Reserve/Watch).
| National Antimicrobial Use (2019) | National Antimicrobial Use (2020) | ||||
|---|---|---|---|---|---|
| Antimicrobials * | DID ** | DIDs% ** | Antimicrobials * | DID ** | DIDs% ** |
| Amoxicillin | 8.39 | 29.56% | Amoxicillin/clavulanic Acid | 4.83 | 17.99% |
| Amoxicillin/clavulanic Acid | 4.82 | 16.97% | Amoxicillin | 3.73 | 13.91% |
| Cefuroxime | 2.37 | 8.34% | Azithromycin | 2.55 | 9.49% |
| Azithromycin | 1.54 | 5.44% | Cefuroxime | 2.31 | 8.60% |
| Ciprofloxacin | 1.53 | 5.40% | Clarithromycin | 1.87 | 6.98% |
| Doxycycline | 1.38 | 4.87% | Ciprofloxacin | 1.85 | 6.89% |
| Cefixime | 1.25 | 4.40% | Cefixime | 1.51 | 5.63% |
| Clarithromycin | 1.21 | 4.26% | Doxycycline | 1.32 | 4.94% |
| Cefalexin | 1.11 | 3.90% | Clindamycin | 1.19 | 4.43% |
| Levofloxacin | 1.02 | 3.58% | Levofloxacin | 0.89 | 3.32% |
| Clindamycin | 0.43 | 1.52% | Metronidazole (IV) | 0.87 | 3.23% |
| Spiramycin/metronidazole | 0.42 | 1.46% | Cefalexin | 0.61 | 2.28% |
| Metronidazole (IV) | 0.39 | 1.39% | Spiramycin/metronidazole | 0.55 | 2.04% |
| Sulfamethoxazole/trimethoprim | 0.36 | 1.36% | |||
* Colour code: Green = Access, amber = Watch. ** DID: DDD per 1000 inhabitants per day.